STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more news

Two drugmakers, Danco Laboratories and GenBioPro, have asked the US Supreme Court to restore mail-order access to the abortion pill mifepristone, while UCB has acquired Candid Therapeutics in a deal worth $2.2 billion to expand its presence in autoimmune disease therapies.